Publications by authors named "Qingxin Mu"

Claim this Profile
A
An Efficient Fabrication Approach for Multi-Cancer Responsive Chemoimmuno Co-Delivery Nanoparticles.
Jianxi Huang, Yu-Ting Chien, Qingxin Mu, Miqin Zhang

Pharmaceutics· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Combination Nanoparticles Containing Gemcitabine and Paclitaxel Enable Orthotopic 4T1 Breast Tumor Regression.
Jesse Yu, Xiaolin Xu, James Ian Griffin, Qingxin Mu, Rodney J Y Ho

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges.
Shujing Ren, Yuhang Xu, Xingpeng Dong, Qingxin Mu, Xia Chen

J Nanobiotechnology· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Editor's challenge: Dr. Qingxin Mu - how can nanomedicine approaches advance multi-targeting strategy in combination cancer therapy?
Marina Pinheiro, Qingxin Mu

Front Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer.
Caroline Linde, Yu-Ting Chien, Zhiqian Chen, Qingxin Mu

Front Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.
James I Griffin, Xinyue Chen, Luqi Duan, Qingxin Mu, Rodney J Y Ho

PLoS One· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Biomedical applications and health impacts of emerging nanostructured materials.
Jianbo Jia, Qingxin Mu, Hongyu Zhou

Front Bioeng Biotechnol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure.
James Griffin, Yan Wu, Qingxin Mu, Xinyan Li, Rodney J Y Ho

Pharmaceutics· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response.
Jesse Yu, Qingxin Mu, Millie Fung, Xiaolin Xu, Linxi Zhu

Pharmacol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzymatic and Cellular Degradation of Carbon-Based Biconcave Nanodisks.
Zhiyong Wei, Qingxin Mu, Hui Wang, Guanyou Lin, Miqin Zhang

Micromachines (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models.
Linxi Zhu, Qingxin Mu, Jesse Yu, James I Griffin, Xiaolin Xu

Pharmaceutics· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Protein Corona Formation: Characterizations, Effects on Engineered Nanoparticles' Biobehaviors, and Applications.
Xue Bai, Jiali Wang, Qingxin Mu, Gaoxing Su

Front Bioeng Biotechnol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A highly selective iron oxide-based imaging nanoparticle for long-term monitoring of drug-induced tumor cell apoptosis.
Guanyou Lin, Qingxin Mu, Richard Revia, Zachary Stephen, Mike Jeon

Biomater Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Long-Acting Drug Combination Nanoparticles Composed of Gemcitabine and Paclitaxel Enhance Localization of Both Drugs in Metastatic Breast Cancer Nodules.
Jesse Yu, Qingxin Mu, Simone Perazzolo, James I Griffin, Linxi Zhu

Pharm Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo Serum Enabled Production of Ultrafine Nanotherapeutics for Cancer Treatment.
Qingxin Mu, Guanyou Lin, Zachary R Stephen, Steve Chung, Hui Wang

Mater Today (Kidlington)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.
Qingxin Mu, Jesse Yu, James I Griffin, Yan Wu, Linxi Zhu

PLoS One· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing a Novel Au-Grafted Lipid Nanoparticle Through Chelation Chemistry for High Photothermal Biologic Activity.
Yu Gao, Qingxin Mu, Lisheng Zhu, Ziying Li, Rodney J Y Ho

J Pharm Sci· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-layer boron-doped graphene quantum dots for contrast-enhanced in vivo T-weighted MRI.
Hui Wang, Richard Revia, Qingxin Mu, Guanyou Lin, Charles Yen

Nanoscale Horiz· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalase-Functionalized Iron Oxide Nanoparticles Reverse Hypoxia-Induced Chemotherapeutic Resistance.
Tin-Yo Yen, Zachary R Stephen, Guanyou Lin, Qingxin Mu, Mike Jeon

Adv Healthc Mater· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook.
Qingxin Mu, Jesse Yu, Lisa A McConnachie, John C Kraft, Yu Gao

J Drug Target· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biconcave Carbon Nanodisks for Enhanced Drug Accumulation and Chemo-Photothermal Tumor Therapy.
Qingxin Mu, Hui Wang, Xinyu Gu, Zachary R Stephen, Charles Yen

Adv Healthc Mater· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitrogen and Boron Dual-Doped Graphene Quantum Dots for Near-Infrared Second Window Imaging and Photothermal Therapy.
Hui Wang, Qingxin Mu, Kui Wang, Richard A Revia, Charles Yen

Appl Mater Today· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Nanoparticles in Cancer Therapy-Novel Concepts, Mechanisms, and Applications.
Qingxin Mu, Bing Yan

Front Pharmacol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron oxide-carbon core-shell nanoparticles for dual-modal imaging-guided photothermal therapy.
Hui Wang, Qingxin Mu, Richard Revia, Kui Wang, Bowei Tian

J Control Release· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chitosan-Gated Magnetic-Responsive Nanocarrier for Dual-Modal Optical Imaging, Switchable Drug Release, and Synergistic Therapy.
Hui Wang, Qingxin Mu, Richard Revia, Kui Wang, Xuezhe Zhou

Adv Healthc Mater· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis